Calithera Biosciences Inc (CALA.OQ)
CALA.OQ on NASDAQ Stock Exchange Global Select Market
5.36USD
15 Feb 2019
5.36USD
15 Feb 2019
Change (% chg)
$0.14 (+2.68%)
$0.14 (+2.68%)
Prev Close
$5.22
$5.22
Open
$5.25
$5.25
Day's High
$5.37
$5.37
Day's Low
$5.12
$5.12
Volume
48,737
48,737
Avg. Vol
69,171
69,171
52-wk High
$9.25
$9.25
52-wk Low
$3.55
$3.55
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 0.00 | -0.518 |
| Jun '18 | 17.07 | -0.086 | |
| Mar '18 | 5.19 | -0.369 | |
| FY 2017 | Dec '17 | 7.25 | -0.308 |
| Sep '17 | 7.25 | -0.171 | |
| Jun '17 | 7.26 | -0.147 | |
| Mar '17 | 4.19 | -0.221 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 2 | 3.00 | 6.00 | 0.00 | -- |
| Quarter Ending Jun-19 | 2 | 3.00 | 6.00 | 0.00 | -- |
| Year Ending Dec-19 | 4 | 13.00 | 28.00 | 0.00 | 9.79 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | 2 | -0.47 | -0.39 | -0.56 | -0.41 |
| Quarter Ending Jun-19 | 2 | -0.49 | -0.39 | -0.58 | -0.51 |
| Year Ending Dec-19 | 5 | -2.08 | -1.52 | -3.22 | -2.47 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 69.44 | 33.70 | |
| P/E High - Last 5 Yrs. | -- | 147.79 | 49.87 | |
| P/E Low - Last 5 Yrs. | -- | 47.97 | 24.25 | |
| Beta | -- | 1.08 | 0.90 | |
| Price to Sales (TTM) | 53.46 | 49.51 | 6.29 | |
| Price to Book (MRQ) | 3.76 | 10.14 | 5.26 | |
| Price to Tangible Book (MRQ) | 3.77 | 13.78 | 6.77 | |
| Price to Cash Flow (TTM) | -- | 56.20 | 24.98 | |
| % Owned Institutions | 90.00 | 3.74 | 1.69 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.12 | 1.40 | |
| Dividend Yield - 5 Year Avg | -- | 0.09 | 1.42 | |
| Dividend 5 Year Growth Rate | -- | 0.79 | 4.85 | |
| Payout Ratio(TTM) | -- | 7.02 | 41.03 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 205.92 | 12.75 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 48.79 | 5.84 | |
| Sales - 5 Yr. Growth Rate | -- | 22.76 | 11.23 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 73.06 | 75.85 | 47.15 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 37.17 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 11.98 | 10.85 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 9.07 | 15.20 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.24 | 2.25 |
| Current Ratio (MRQ) | 4.95 | 3.50 | 3.08 |
| LT Debt to Equity (MRQ) | 0.00 | 18.65 | 11.38 |
| Total Debt to Equity (MRQ) | 0.00 | 31.33 | 16.12 |
| Interest Coverage (TTM) | -- | -43.11 | 29.47 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 56.24 | 53.81 | |
| Gross Margin - 5 Yr. Avg. | -- | 60.48 | 52.18 | |
| EBITD Margin (TTM) | -256.99 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -110.40 | 12.87 | |
| Operating Margin (TTM) | -259.69 | -184.63 | 6.20 | |
| Operating Margin - 5 Yr. Avg. | -- | -126.89 | 8.31 | |
| Pre-Tax Margin (TTM) | -251.99 | -175.33 | 7.16 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -132.68 | 8.61 | |
| Net Profit Margin (TTM) | -251.99 | -182.03 | 3.30 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -137.07 | 4.89 | |
| Effective Tax Rate (TTM) | -- | 22.48 | 22.91 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 15.51 | 23.38 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 228,940 | 7,654,601 | 842,398,385 | |
| Net Income/Employee (TTM) | -576,900 | 562,114 | 99,842,801 | |
| Receivable Turnover (TTM) | -- | 6.23 | 5.71 | |
| Inventory Turnover (TTM) | -- | 1.89 | 3.47 | |
| Asset Turnover (TTM) | 0.08 | 0.32 | 0.93 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -20.80 | 6.39 | 11.06 | |
| Return on Assets - 5 Yr. Avg. | -- | 5.47 | 12.20 | |
| Return on Investment (TTM) | -24.22 | 8.92 | 14.45 | |
| Return on Investment - 5 Yr. Avg. | -- | 6.78 | 15.87 | |
| Return on Equity (TTM) | -26.14 | 10.08 | 15.96 | |
| Return on Equity - 5 Yr. Avg. | -- | 8.32 | 17.00 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -7.81 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Calithera Biosciences Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 6.15 | 2.49 | 99 | 99 |
| 13 Week | -3.63 | -8.32 | 86 | 95 |
| 26 Week | 53.33 | 41.68 | 99 | 98 |
| 52 Week | 429.14 | 348.49 | 99 | 72 |
| YTD | 430.77 | 366.12 | 99 | 72 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 69.84% |
| # of Holders: | 121 |
| Total Shares Held: | 26,626,957 |
| 3 Mo. Net Change: | 1,815,012 |
| # New Positions: | 13 |
| # Closed Positions: | 15 |
| # Increased Positions: | 43 |
| # Reduced Positions: | 51 |
| # Net Buyers: | -8 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.